20 (AIDX) Change in Accured Expenses (2025 - 2026)
20 (AIDX) reported Change in Accured Expenses of $26634.0 for Q1 2026, down 79.42% on a YoY basis from $129413.0 in Q1 2025, and down 79.42% quarter-over-quarter from $129413.0 in Q1 2025.
20 (AIDX) Change in Accured Expenses (2025 - 2026) Analysis & Trends
20 has reported Change in Accured Expenses for 2 years, with the latest figure at $26634.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | 20 | - | - | 62,884.00 | 26,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,634.00 |
| Mar 31, 2026 | 26,634.00 |
| Mar 31, 2025 | 129,413.00 |
| Mar 31, 2025 | 129,413.00 |